|
Market Cap (4-Jul) $592,261,248 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 22 January 2021, 11:11. The announcement is marked as price sensitive, and is 8 page(s) in length and 319.75kb in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.321% short sold according to ASIC data. It was ranked the 331st most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Appendix 4C - Quarterly | 22 January 2021, 11:11 |
| Antimicrobial Data Published in Peer-Reviewed Journal | 20 January 2021, 8:24 |
| Appendix 2A and Notice Under Section 708A | 17 December 2020, 17:14 |
| Update on BTX 1801 Phase 2a Clinical Study | 14 December 2020, 9:25 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 